Skip to main content
NIH funding notice RFA-HL-15-013

Cardiovascular Development Consortium (UM1)

Closed on October 15, 2014.

Posted
July 8, 2014
Close date
October 15, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
4
1 new, 3 renewals
Median first-year cost
$854,866
$3,401,232 in all
Institutions
4
4 contact PIs
Patents
3
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. HARVARD MEDICAL SCHOOL1
  2. J. DAVID GLADSTONE INSTITUTES1
  3. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
  4. UNIVERSITY OF UTAH1

Most frequent study sections

  1. Special Emphasis Panel (ZHL1 CSR-H (M2))4
4 awards under RFA-HL-15-013 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2015The Epigenetic Landscape of Heart Development2UM1HL098179-07Bruneau, Benoit GaetanPollard, Katherine S.Srivastava, DeepakJ. DAVID GLADSTONE INSTITUTES, CAFirst-year cost $946,500Study section ZHL1
FY2015Regulation of Cardiac Development in Health and Disease2UM1HL098166-07Pennacchio, Len AlexanderPu, William TswenchingSeidman, Christine ESeidman, Jonathan GVisel, AxelHARVARD MEDICAL SCHOOL, MAFirst-year cost $914,286Study section ZHL1
FY2015Developmental Regulatory Genomics of Human Cardiovascular Lineages1UM1HL128773-01Chi, Neil CEvans, Sylvia MUNIVERSITY OF CALIFORNIA, SAN DIEGO, CAFirst-year cost $795,446Study section ZHL1
FY2015Genome-Wide Analysis of Cardiac Development in Zebrafish2UM1HL098160-07Yost, H. JosephUNIVERSITY OF UTAH, UTFirst-year cost $745,000Study section ZHL1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

3 patents name 1 of the 4 funded projects.

  1. US 11,236,383 (opens the patent at USPTO, a PDF, in a new tab)DETECTION OF GENOME EDITINGGranted February 1, 2022 to Bio-Rad Laboratories, Inc. and The J. David Gladstone InstitutesUM1HL098179 · J. DAVID GLADSTONE INSTITUTES, CA
  2. US 11,020,463 (opens the patent at USPTO, a PDF, in a new tab)METHOD OF DETERMINING CELLULAR PROTEIN HOMEOSTASISGranted June 1, 2021 to The J. David Gladstone Institutes and THE REGENTS OF THE UNIVERSITY OF CALIFORNIAUM1HL098179 · J. DAVID GLADSTONE INSTITUTES, CA
  3. US 10,280,451 (opens the patent at USPTO, a PDF, in a new tab)Detection of Genome EditingGranted May 7, 2019 to Bio-Rad Laboratories, Inc. and The J. David Gladstone InstitutesUM1HL098179 · J. DAVID GLADSTONE INSTITUTES, CA

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-HL-15-013: Cardiovascular Development Consortium (UM1) | ScienceDex | ConductScience